This section contains technical information intended for healthcare professionals only.
By continuing, I acknowledge iam a qualified healthcare professional and agree to use this information responsibly within your scope of practice.
In this section you will find information on the product TendoVis™ and its use in the treatment of tennis elbow / epicondylalgia. We have included TendoVis™ prescribing information, clinical references, and other useful information.
If you require further assistance, please contact us.
The main content of TendoVis™ is STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid).
TendoVis™ is a registered product with the CE mark, and both TendoVis™ and the manufacturing process for STABHA™ are patented.
TendoVis™ treats tennis elbow via peri-articular injection. The fanning technique ensures optimal interaction with the tendon structure by evenly spreading TendoVis™ across the injury site.
A clinical study against placebo has shown that patients in the TendoVis™ group were able to return to sports activity within 18 (±11) days. This was not seen in the control group.
By interacting with the collagen fibres in the tendon, biocompatible TendoVis™ facilitates the fibres into their normal parallel alignment for faster healing. TendoVis™ also acts as a structural support and lubricant at the injury site to improve the healing process.
TendoVis™ containing STABHA™ (Soft Tissue Adapted BIOCOMPATIBLE Hyaluronic Acid) will help reduce the pain in tennis elbow / epicondylalgia due to these ancillary effects with low probability of systemic side effects.
Hyaluronic acid has an ancillary effect of reducing pain and limiting inflammation. TendoVis™ containing STABHA™ will help reduce pain and limit inflammation due to these ancillary effects with a low probability of systemic side effects (none experienced during clinical trials until now).
TendoVis™ contains STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid), specifically formulated for optimal interaction with ligaments and tendons due to its high purity and biocompatibility.
Once injected into the injury site, STABHA™ binds to the injured tendons, reinforcing the fibrin network and supporting the healing process.
Using the fanning technique, TendoVis™ is evenly distributed across the injury site, saturating the area for maximum therapeutic effect and accelerated recovery.
Incorporating TendoVis™ into the R.I.C.E. standard of care not only accelerates recovery but also ensures a comprehensive approach to managing tennis elbow effectively.
TendoVis™ is a peri-articular injection that can only be performed by a medical professional that has been trained in the injection technique. TendoVis™ should be injected into the injury site and the 2nd injection shall be administered 1 week following the 1st injection.
Rest: Avoid activity to prevent further injury.
Ice: Apply 15-20 minutes per hour to reduce swelling.
Compression: Use a bandage to manage swelling and support the area.
Elevation: Keep the injured area elevated above heart level when resting.
Using TendoVis™ together with the R.I.C.E. standard of care will allow the patient to regain mobility and experience less pain more quickly.
Find out more about other soft tissue injuries
For inquiries related to sales, quality, or customer service, our team is ready to help.v
A product designed to relieve the pain and optimise the recovery of acute and chronic soft tissue injuries
